Business Context and Reporting Period
Company: Landec Corporation (LNDC)
Filing Type: Form 10-K (Annual Report)
Period Ended: May 27, 2007
Business Overview: Landec designs, develops, and sells temperature-activated specialty polymer products. Operations are divided into two core segments: Food Products Technology (via subsidiary Apio, Inc., focusing on fresh-cut produce packaging) and Agricultural Seed Technology (via Landec Ag, Inc., focusing on seed coatings). The company also maintains a Technology Licensing/R&D business.
Key Financial Metrics
| Metric | Fiscal 2007 | Fiscal 2006 |
|---|---|---|
| Total Revenues | $210.5 million | $232.0 million |
| Gross Profit | $32.4 million | $40.0 million |
| Operating Profit | $30.4 million | $9.0 million |
| Net Income | $29.2 million | $8.7 million |
| Diluted EPS | $1.07 | $0.32 |
| Cash and Equivalents | $62.6 million | $15.2 million |
| Total Debt | $28,000 | $2.0 million |
Note: Operating profit and Net Income for 2007 include a significant non-recurring gain from the sale of a business unit.
Material Changes vs. Prior Period
- Strategic Divestiture: On December 1, 2006, Landec sold its direct marketing and sales seed company, Fielder's Choice Direct (FCD), to American Seeds, Inc. (a Monsanto subsidiary) for $50 million. This resulted in a recorded income of $22.7 million in fiscal 2007.
- Revenue Composition: Total revenues declined 9% to $210.5 million. This decrease was driven by a 92% drop in Landec Ag revenues ($2.8 million vs. $34.1 million) due to the FCD sale. Conversely, the Food Products Technology segment (Apio) grew 6% to $206.2 million, with value-added sales increasing 14%.
- Profitability Surge: Net income increased 237% to $29.2 million. This was primarily due to the $22.7 million gain on the FCD sale. Excluding this gain, core operating performance remained relatively stable, though gross profit declined 19% due to the loss of FCD product sales.
- Liquidity Improvement: Cash and cash equivalents increased by $47.4 million (313%) to $62.6 million, largely funded by the $49.4 million net proceeds from the FCD sale.
- Debt Reduction: Total debt decreased significantly to $28,000 as the company paid off Apio's long-term bank debt and the FCD line of credit was assumed and paid by the buyer.
Outlook, Risks, and Management Commentary
- Monsanto Agreement: Following the FCD sale, Landec entered a five-year co-exclusive technology license and supply agreement with Monsanto. Landec expects to recognize $5.4 million in annual revenue and operating income from this agreement for fiscal years 2008 through 2011.
- Food Segment Growth: Management highlights growth in the Apio value-added segment, driven by new product introductions (15 new products in 2007) and expanded sales to existing customers. The company is expanding its export business to Asia.
- Risk Factors:
- Customer Concentration: The top five customers accounted for 50% of revenues, with Costco Wholesale Corp. representing 21%.
- Weather and Supply: The food business is subject to weather-related crop shortages, which can increase sourcing costs and reduce volumes.
- Single-Source Suppliers: Certain raw materials for Intelimer polymers are purchased from single sources, creating supply chain risks.
- Intellectual Property: Success depends on maintaining patent protection and avoiding infringement claims.
- Capital Allocation: The company plans to use its strong cash position to fund R&D, capital expenditures (including Apio facility automation), and potential strategic acquisitions.
Investor Verification Checklist
- Sustainability of Earnings: Verify the extent to which future profitability relies on the recurring $5.4 million annual revenue from the Monsanto license versus the one-time $22.7 million gain from the FCD sale.
- Customer Concentration: Assess the risk associated with Costco Wholesale Corp. accounting for 21% of total revenues and the potential impact of order cancellations.
- Operational Margins: Review the gross margin trends in the Apio value-added segment, specifically regarding the impact of weather-related produce shortages on sourcing costs.
- Intellectual Property Portfolio: Confirm the status of the 27 active patents and any pending litigation regarding the Intelimer polymer technology.
- Cash Utilization: Monitor the deployment of the $62.6 million cash balance to ensure it supports R&D and growth initiatives without diluting shareholders.